Clinical Trial Update: A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating BI 1356225 to improve impulsive behavior in people with opioid use disorder who are taking bupre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• BI 1356225

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Opioid Use Disorder | Phase 1 | Status: RECRUITING